Sanguina, LLC

Atlanta, GA · Medtech · Private

Fingerstick blood test and smartphone app for non-invasive hemoglobin measurement and anemia screening

Claim this profile

Follows are private to you and power your alerts

Updated Oct 23, 2026

Sector: Medtech
Headquarters: Atlanta, GA
Total capital: $4.8M

Federal grants: $4.8M; 9 awards · 2015–2024; Rank in peer group#132 of 538
Private capital raised: None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
Federal contracts: None on recordNo federal contract awards found.
Granted patents: 0; 1 pending

Capital timeline

Latest events

Dec 2024Federal grantHealth and Human S · Phase II · Translation of a personalized, non-invasive smartphone app for hemoglobin monitoring for chronic anemia patients$1M
Dec 2023Federal grantHealth and Human S · Phase II · Translation of a personalized, non-invasive smartphone app for hemoglobin monitoring for chronic anemia patients$987K
May 2022Federal grantHealth and Human S · Phase II · SBIR phase II: A personalized, non-invasive hemoglobin level monitoring and management platform for chronic anemia patients.$699K
Aug 2021Federal grantHealth and Human S · Phase II · SBIR phase II: A personalized, non-invasive hemoglobin level monitoring and management platform for chronic anemia patients.$1.4M
Sep 2019Federal grantHealth and Human S · Phase I · On-demand smartphone app for non-invasive anemia detection using only patient-sourced photos in low resource settings.$150K
Aug 2018Federal grantHealth and Human S · Phase I · Administrative Supplement to Promote Diversity for Development of a robust, color-based, disposable, standalone anemia test for low-resource settings (Parent grant: 1 R43 HL139250-01A1)$67K
Aug 2018Federal grantHealth and Human S · Phase I · Concept to Clinical: Commercializing Innovation (C3i) Program for AnemoCheck-D: a robust, color-based, disposable, standalone anemia test for low-resource settings$30K

Show 2 earlier federal awards

Dec 2017Federal grantHealth and Human S · Phase I · HLS- SBIR Phase I: Development of a robust, color-based, disposable, standalone anemia test for low-resource settings$150K
Jun 2015Federal grantNSF · Phase I · STTR Phase I: Development of a novel patient-operated, color-based, disposable diagnostic self-test for anemia$270K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 538 peers

Line = median

Medtech · Device

Federal grants#132 · top 25%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

No founders are linked to this company yet.

Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.

Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026

Claim this profile to add your team

What it has protected

USPTO · 0 granted of 1

PendingSystems and Methods for Quantitative Diagnosis of AnemiaUSPTOApplication 62755930

HEALING INNOVATIONS INCSimilar federal contract value in Medtech · null in contracts
CerFlux, Inc.Similar federal contract value in Medtech · null in contracts
NEUROLOGICAL REHABILITATION VIRTUAL REALITY, L.L.C.Similar federal contract value in Medtech · null in contracts
Neptune Fluid Flow Systems LLCSimilar federal contract value in Medtech · null in contracts
Cambre KellySimilar federal contract value in Medtech · null in contracts
InnovasonicSimilar federal contract value in Medtech · null in contracts

Regulatory activity · Medtech

Sector-level, not company-level

07 Jul 2026New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
30 Jun 2026Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
30 Jun 2026Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
29 Jun 2026Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
26 Jun 2026Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
26 Jun 2026Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through Oct 23, 2026. SBIR and STTR awards through Oct 21, 2026.